Full-Time

Community Health Nurse

Updated on 8/20/2026

Deadline 8/11/27
Fraser Health

Fraser Health

10,001+ employees

Public health authority operating hospitals

Compensation Overview

CA$41.42 - CA$59.52/hr

Coquitlam, BC, Canada + 2 more

More locations: Port Coquitlam, BC, Canada | Port Moody, BC, Canada

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Electronic Health Records (EHR)
Risk Management
Care Coordination

Get referred to Fraser Health

See people who can refer or advise you

Requirements
  • Current practicing registration as a Registered Nurse with the British Columbia College of Nurses and Midwives.
  • One year of recent related clinical experience assessing and treating complex geriatric and/or adult patients with chronic health conditions in an acute or community/outpatient care setting, including recent experience in care and discharge planning, or an equivalent combination of education, training and experience.
  • A valid British Columbia driver's license and access to a personal vehicle for business-related purposes.
  • Knowledge, skills and competence in gerontology and adults living with complex frailty and chronic illnesses.
  • Ability to complete initial and ongoing client assessments and provide nursing care through therapeutic interventions.
  • Ability to communicate effectively, both verbally and in writing.
  • Ability to integrate and evaluate pertinent data from multiple sources to solve problems effectively.
  • Knowledge of broad health care services, community resource agencies and their role in providing a continuum of care.
  • Ability to promote client-focused care with sensitivity to diverse cultures and preferences.
  • Ability to independently manage and prioritize clients with diverse healthcare issues.
  • Ability to teach clients and others about topics essential to health care, health promotion and care self-management using care management principles.
  • Ability to work effectively in a dynamic environment with changing priorities.
  • Ability to work independently and as a member of an interprofessional team.
  • Ability to operate related equipment, including applicable software applications.
  • Physical ability to perform the duties of the position.
Responsibilities
  • Establish a therapeutic relationship with clients through interpersonal and interviewing techniques, in person and/or by telephone, while supporting client choice, autonomy, dignity and privacy in decision-making and care planning.
  • Screen referrals and provide individualized client assessments, interprofessional care planning, clinical interventions and referral services for clients with multiple complex chronic conditions.
  • Collaborate with primary care providers, clients, families, caregivers, healthcare professionals, clinics, hospitals and community resources to resolve client care issues and coordinate integrated care and services.
  • Develop comprehensive shared patient or client care plans with the interprofessional team, primary care providers, clients, families, healthcare providers and referring clinics.
  • Facilitate and support transitions of client care plans to referring sources, primary or community care providers and community agencies.
  • Provide direct client care and identify additional care services required in accordance with applicable guidelines, policies and evidence-based best practices.
  • Make decisions about client-specific direct care tasks, assign tasks to Community Health Workers, and delegate client-specific tasks when appropriate.
  • Provide in-home demonstrations and training for assigned and delegated client-specific tasks and ensure Community Health Workers have the necessary knowledge, skills and support to perform them within defined limits.
  • Collaborate with the Community Health Nurse–Licensed Practical Nurse in monitoring Community Health Workers who perform delegated direct care tasks.
  • Facilitate care conferences to review client care plans and determine the timing of referrals to other services or interventions.
  • Initiate, monitor and evaluate short- and long-term care plans, develop next steps with clients and families, and support transitions across the care continuum, including discharge or transfer.
  • Discuss clinical findings with clients and families, develop action plans and goals for clinical needs, self-management, self-care and improved health-related quality of life.
  • Review client data, including medical histories, progress notes, consultation reports and laboratory reports, and incorporate findings into care plans.
  • Plan, organize and prioritize work using resources effectively and efficiently, and respond to unanticipated events or changing client or service assignment needs.
  • Support clients and families before, during and after interprofessional conferences and clinic visits by providing information about treatment options and decision-making.
  • Advocate for clients and families and provide direct care in clinic, community and home settings as clients transition to other programs, services or healthcare providers.
  • Arrange and participate in joint home visits with clients, families and other healthcare professionals and advise clients or caregivers about available community resources.
  • Provide health counselling, education, self-management, self-monitoring and wellness, health promotion and prevention through clinic, telephone and home visits.
  • Collaborate with healthcare professionals in clinics, community programs and services to facilitate information flow across primary and community care settings.
  • Maintain clinical records, including intake screens, client assessments, clinical interventions, treatment formulations, care plans and progress notes, and maintain client statistics according to established policies, standards and procedures.
  • Maintain professional practice growth, knowledge and expertise by reviewing relevant literature, attending educational workshops and in-services, and consulting and networking with healthcare professionals.
  • Participate in department quality improvement and risk management activities by identifying client care issues and collecting data.
  • Participate in research opportunities as required.
  • Participate in the orientation and ongoing education of nursing staff and students by providing information and acting as a preceptor when appropriate.
  • Provide input into the development and revision of standards of care, policies and procedures and advocate for improvements in clinical practice, healthcare and healthcare services.
  • Participate in developing, implementing and evaluating program quality improvement initiatives by providing recommendations to the Manager.
  • Perform other related duties as assigned.

Fraser Health is a health authority in British Columbia that provides a wide range of medical services to about 1.8 million people. It operates 12 hospitals, including major trauma centres, plus an outpatient care and surgery centre, and offers residential care, home health, public health, and mental health services. The organization employs over 40,000 staff, medical professionals, and volunteers who run clinics, care centres, and community programs. Its goal is to deliver accessible, high-quality care across the network while creating good workplaces for its employees and volunteers.

Company Size

10,001+

Company Stage

Grant

Total Funding

$20K

Headquarters

Surrey, Canada

Founded

2001

Get referred to Fraser Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Fraser Health won $1.3 million March 2026 to expand Indigenous elder home care.
  • Royal Columbian Hospital activated March 24, 2026, adding one more clinical-trial site.
  • Surrey’s new UPCC opened January 28, 2026, targeting 64,000 annual patient visits.

What critics are saying

  • Mission Memorial’s ED shut down May 25, 2026, exposing persistent physician staffing gaps.
  • Peace Arch maternity closed for the sixth time in March 2026, signaling brittle coverage.
  • Cloverdale hospital costs reached $2.88 billion, and completion slipped to August 2029.

What makes Fraser Health unique

  • Fraser Health runs 12 hospitals across 20 communities, anchoring Lower Mainland acute care.
  • Its Indigenous-led home-care programs integrate Stó:lō, FNHA, and Métis partners.
  • Fraser Health is deploying AI scheduling with Deloitte and Scale AI across hospitals.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

11%

1 year growth

11%

2 year growth

11%
StockTitan
Mar 24th, 2026
Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II cardiac surgery-associated AKI trial.

Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II cardiac surgery-associated AKI trial. Rhea-AI Impact Rhea-AI Sentiment Rhea-AI summary. Arch Biopartners (OTCQB: ACHFF) announced a Clinical Trial Agreement with Fraser Health Authority to prepare Royal Columbian Hospital for recruitment in its Phase II trial of LSALT peptide for prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). Royal Columbian Hospital is now the ninth global site activated and the fourth Canadian recruiting site, after Toronto General Hospital, St. Michael's Hospital, and University of Calgary. Positive. * Royal Columbian Hospital received final Research Ethics Board and operational approvals * Royal Columbian Hospital became the 9th global site activated in the Phase II CS-AKI trial * 4 Canadian sites are actively recruiting patients (Toronto General, St. Michael's, Calgary, RCH) Negative. 03/24/2026 - 09:13 AM TORONTO, March 24, 2026 (GLOBE NEWSWIRE) - Arch Biopartners Inc. ("Arch" or the "Company") (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Fraser Health Authority has entered into a Clinical Trial Agreement ("CTA") with Arch to enable the Royal Columbian Hospital (RCH) to begin preparing for the recruitment phase in Arch's ongoing Phase II trial evaluating LSALT peptide for the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). With the Clinical Trial Application (CTA) completed, RCH has now received final Research Ethics Board and operational approvals, including the final letter of authorization from Fraser Health. RCH will be the ninth site activated globally in the study and will be the fourth site to recruit patients in Canada. Toronto General Hospital, part of University Health Network, St. Michael's Hospital, part of Unity Health Toronto, and the University of Calgary, Cumming School of Medicine, continue to actively enroll new patients into the trial. The Company is currently progressing feasibility and start-up discussions with additional leading cardiac surgery centres in Canada and the United States. About Arch Biopartners Arch Biopartners Inc. is a therapeutic biotech company developing novel drugs for acute kidney injury (AKI) and chronic kidney disease (CKD). The Company is advancing an integrated program that includes new treatments targeting inflammation- and toxin-related kidney injury. Arch's development pipeline includes: * LSALT peptide: in a Phase II trial targeting cardiac surgery-associated AKI. * Cilastatin: a repurposed drug in a Phase II trial targeting toxin-induced AKI. * CKD Platform: next-generation therapeutics targeting chronic kidney disease. These assets represent distinct, mechanism-based approaches to treating and preventing common causes of kidney damage. Together, they target serious unmet needs in kidney care across both chronic and acute indications, affecting more than 800 million people worldwide[1]. Both lead programs are currently enrolling patients at Canadian clinical sites, with additional North American sites in development. For more details about the Company's science and ongoing clinical trials, please visit: www.archbiopartners.com/our-science Follow Arch on LinkedIn, Bluesky, and X (formerly Twitter) for scientific insights and industry news. The Company has 66,933,289 common shares outstanding. | Aaron Benson Director of Communications Arch Biopartners, Inc. 647-428-7031 | / | | / | / | Send a message or subscribe for trial updates and company news at www.archbiopartners.com/contact-us Forward-Looking Statements This press release contains forward-looking statements within the meaning of applicable Canadian securities laws regarding expectations of the Company's future performance, liquidity, and capital resources, as well as the ongoing development of its drug candidates targeting chronic kidney disease and the dipeptidase-1 (DPEP-1) pathway, including the outcome of its clinical trials relating to LSALT peptide (Metablok) or cilastatin, the successful commercialization and marketing of its drug candidates, whether the Company will receive, and the timing and costs of obtaining, regulatory approvals in Canada, the United States, Europe, and other countries, its ability to raise capital to fund its business plans, the efficacy of its drug candidates compared to the drug candidates developed by competitors, its ability to retain and attract key management personnel, and the breadth of, and its ability to protect, its intellectual property portfolio. These statements are based on management's current expectations and beliefs, including certain factors and assumptions, as described in the Company's most recent annual audited financial statements and related management discussion and analysis under the heading "Business Risks and Uncertainties". As a result of these risks and uncertainties, or other unknown risks and uncertainties, the actual results may differ materially from those contained in any forward-looking statements. The words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect", and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company undertakes no obligation to update forward-looking statements, except as required by law. Additional information relating to Arch Biopartners Inc., including the Company's most recent annual audited financial statements, is available by accessing the Canadian Securities Administrators' System for Electronic Document Analysis and Retrieval ("SEDAR") website at www.sedarplus.ca. References: * Mark, Patrick B et al. Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, 2025;406(10518), 2461 - 2482. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01853-7/fulltext The scientific and medical content of this release has been reviewed and approved by the Company's Chief Science Officer. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Faq. What does the Clinical Trial Agreement with Fraser Health mean for Arch Biopartners (ACHFF)? It enables Royal Columbian Hospital to prepare for patient recruitment in the Phase II CS-AKI trial. According to the company, RCH now has final Research Ethics Board and operational approvals plus a letter of authorization from Fraser Health, supporting site activation. How many sites are active in Arch Biopartners' (ACHFF) Phase II LSALT CS-AKI trial after Royal Columbian Hospital activation? Royal Columbian Hospital is the ninth site activated globally in the study. According to the company, RCH is also the fourth site in Canada to reach activation and prepare for recruitment. Which Canadian hospitals are currently recruiting for Arch Biopartners' (ACHFF) Phase II CS-AKI trial? Toronto General Hospital, St. Michael's Hospital, University of Calgary, and now Royal Columbian Hospital are recruiting. According to the company, those four Canadian centres are actively enrolling new patients into the trial. What approvals did Royal Columbian Hospital receive to start recruitment for the ACHFF Phase II trial? RCH received final Research Ethics Board and operational approvals plus a letter of authorization from Fraser Health. According to the company, these approvals complete site readiness for recruitment and study start-up activities. Will Arch Biopartners (ACHFF) add more sites in Canada and the US for the Phase II CS-AKI trial? The company is progressing feasibility and start-up discussions with additional cardiac surgery centres in Canada and the United States. According to the company, those discussions aim to expand site activation beyond the current nine global sites.

Black Press Media
Mar 14th, 2026
$1.3M funding will help more Indigenous elders in Chilliwack with at-home care

$1.3M funding will help more Indigenous elders in Chilliwack with at-home care. Published 8:45 am Saturday, March 14, 2026 An at-home program that offers care to Indigenous elders in the Fraser Valley will be expanding, with the main focus on Chilliwack, thanks to $1.3 million in new funding. The Indigenous Caregiver Support Model (ICSM) is a home-based program that supports elders with "complex needs to age safely at home and in their community," according to a Fraser Health press release. It is one of five programs in B.C. benefitting from a total of $6.3 million in funding from Health Research BC over the next three years. The funding will advance research to help B.C. seniors age comfortably in their own home. The ICSM program was launched in 2023 as a pilot project and has supported 33 elders and their caregivers in the Eastern Fraser Valley, including Chilliwack. Its aim is to reduce caregiver strain and improve elder wellbeing by providing culturally safe, coordinated in-home support, training, and financial assistance for Indigenous families caring for elders. It is co-designed by Fraser Health Indigenous Health, Stó:lō Service Agency, First Nations Health Authority, and Métis Nation British Columbia. "This model is an example of what is possible when care is built on relationships, trust and community," said Amanda LaBoucane, interim vice president, Indigenous Health and Cultural Safety. "Many elders and caregivers in the Chilliwack area have experienced firsthand the impacts of residential schools and the child welfare system. By strengthening caregiver capacity and confidence while bridging into integrated clinical care teams run by and for Indigenous people, we see improved health and wellness and stronger relationships within and between communities." The program is currently operating in the Fraser Valley, including Chilliwack, but the expansion will focus on urban Chilliwack as that is an identified need, said Carrie Stefanson with Fraser Health. Caregivers receive skills training and an honorarium to help reduce the economic strain of caregiving, while elders receive regular home visits from Indigenous-led clinical teams who provide culturally safe, relationship-based care, rooted in trust, kindness and respect, according to a Fraser Health.

Fraser Health
Sep 12th, 2024
Leveraging artificial intelligence to assist with scheduling

Fraser Health has partnered with Deloitte Canada to develop and launch scheduling tools that leverage artificial intelligence (AI) and machine-learning solutions to accurately forecast the waves in demand Fraserhealth see in the health system.

Government of British Columbia
Aug 22nd, 2024
Permanent supportive, complex-care homes open in Fraser Valley

For people not already connected to services, Fraser Health will work in partnership with Coast Mental Health to provide on-site clinical supports, including services from a psychiatric nurse, community nurse, licensed practical nurse, social worker and traditional wellness practitioners.

Daily Hive
Sep 12th, 2023
Construction begins on Surrey's new $2.9 billion Cloverdale hospital

Through a procurement process, Fraser Health has selected Ellis-Don Design Build to design and build the new facility through a design-build agreement.